[ XXXX , antiandrogen treatment and cardiovascular risk].

@entity1 @entity263 @entity6 @entity342 @entity855
AIM: To assess if cardiovascular risk (CVR) charts are able to identify the increased risk caused by @entity342 deprivation therapy (ADT) in @entity1 with @entity263 ( @entity263 ). DESIGN: Retrospective cohort study. LOCATION: Urban and rural health centres in the province of Ourense. @entity1 : @entity1 diagnosed with @entity263 who had been prescribed treatment for ADT between 2007 and 2008. MAIN MEASURES: Age, residence (rural/urban), staging (Gleason), diagnostic procedure and, at the beginning and end of follow-up, lipid profile, blood pressure, diagnosis of @entity6 , smoking, use of antihypertensive and lipid-lowering drugs, and Framingham calibrated and ATP III indexes, were determined. Cardiovascular events were recorded during the follow-up. Each @entity1 was his own control. Increasing age was not used in the calculation of the scores at the end of the follow up period. The scores were compared using the t-test for paired samples (SPSS 15.0). RESULTS: A total of 209 cases were included. The mean (SD) age was 73.8 (8.0) years, with 64.6% of urban cases. The scores at baseline and at 12 months of follow-up were: Framingham 9.0 (4.6) and 9.2 (4.8) (P=0.5), @entity855 III 14.2 (1.7) and 14.2 (1.7) (P=0.9). CONCLUSION: CVR charts do not assess the increased risk associated with @entity342 deprivation therapy in @entity263 .
